NEW YORK – Thermo Fisher Scientific said on Wednesday that it has priced an offering of $2.5 billion in senior notes.
According to the firm, $1.0 billion of senior notes due 2026 with an interest rate of 5 percent will have an issue price of 99.931 percent of their principal amount, $1.0 billion of senior notes due 2029 with an interest rate of 5 percent will have an issue price of 99.772 percent of their principal amount, and $500 million of senior notes due 2034 with an interest rate of 5.2 percent will have an issue price of 99.846 percent of their principal amount.
The offering is expected to close on or about Dec. 5, subject to customary closing conditions, and the notes will pay interest on a semiannual basis.
Thermo Fisher said it plans to use the proceeds for general corporate purposes, which may include the acquisition of companies or businesses, repayment and refinancing of debt, working capital, and capital expenditures.
The joint bookrunning managers for the notes are BofA Securities, Morgan Stanley, US Bancorp Investments, and Wells Fargo Securities.